Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Tech Reporter.
Press releases published on April 23, 2025
ROKiT's ABK Beer Wins Three Category Awards at the London Beer Competition 2025
EIN Presswire
·
April 23, 2025
Winning awards at the London Beer Competition means that ABK Edel Spezialbier stood out in one of the most demanding tasting rooms in the industry LONDON, UNITED KINGDOM, April 23, 2025 /EINPresswire.com/ -- ABK Beer, part of ROKiT Spirit, is proud to …
EBC Financial Group Perluas Jangkauan Global Lewat iFX EXPO 2025 di LATAM, Tegaskan Komitmen Akses Trading Inklusif
EIN Presswire
·
April 23, 2025
Mulai dari literasi finansial hingga akses platform, EBC hadir sebagai solusi khusus untuk pasar investor di LATAM yang berkembang pesat. MEXICO, April 23, 2025 /EINPresswire.com/ -- EBC Financial Group (EBC) bergabung dengan para pemimpin pemikiran …
Brag House Provides Update on Status of Form 10-K Filing and Reiterates Commitment to SEC Compliance Obligations
GlobeNewswire
·
April 23, 2025
NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- Brag House Holdings, Inc. (NASDAQ: TBH), a pioneering media-tech platform at the intersection of gaming, college sports, and social interaction, continues to diligently work on its Form 10-K for the fiscal year- …
Alta Equipment Group Announces Date of First Quarter 2025 Financial Results Release, Conference Call and Webcast
GlobeNewswire
·
April 23, 2025
LIVONIA, Mich., April 23, 2025 (GLOBE NEWSWIRE) -- Alta Equipment Group Inc. (NYSE: ALTG) (“Alta” or “the Company”), a leading provider of premium material handling, construction and environmental processing equipment and related services, today announced …
Plexus Announces Fiscal Second Quarter Financial Results
GlobeNewswire
·
April 23, 2025
NEENAH, WI, April 23, 2025 (GLOBE NEWSWIRE) -- Plexus Corp. (NASDAQ: PLXS) today announced financial results for our fiscal second quarter ended March 29, 2025, and guidance for our fiscal third quarter ending June 28, 2025. Reports fiscal second quarter …
Palvella Therapeutics Announces Abstract Highlighting the Estimated Diagnosed Prevalence and Annual Incidence of Lymphatic Malformations in the U.S. Accepted for Poster Presentation at the 82nd Annual Meeting of the Society for Investigative Dermatology
GlobeNewswire
·
April 23, 2025
Quantitative analysis of medical claims indicates an estimated 44,553 to 92,967 diagnosed U.S. patients with lymphatic malformations (LMs) with cutaneous involvement Estimates of annual incidence of LMs with cutaneous involvement to be highlighted in the …
Iovance Biotherapeutics Announces Participation in Upcoming Scientific Congresses
GlobeNewswire
·
April 23, 2025
SAN CARLOS, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with …
Silvaco Announces Date of First Quarter 2025 Financial Results Conference Call
GlobeNewswire
·
April 23, 2025
SANTA CLARA, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Silvaco Group, Inc. (Nasdaq: SVCO, “Silvaco”), a provider of TCAD, EDA software, and SIP solutions that enable innovative semiconductor design and digital twin modeling through AI software and …
Corvus Pharmaceuticals to Present New Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis on May 8, 2025
GlobeNewswire
·
April 23, 2025
Data from Cohorts 1-3 of trial to be presented in an oral session and poster at the Society for Investigative Dermatology (SID) 2025 Annual Meeting Company to discuss data on its first quarter 2025 business update conference call and webcast scheduled for …
Aligos Therapeutics Announces Eight Abstracts Accepted for Presentation at the EASL Congress 2025
GlobeNewswire
·
April 23, 2025
SOUTH SAN FRANCISCO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …
Inotiv, Inc. to Report Fiscal 2025 Second Quarter Financial Results and Host Conference Call on Wednesday, May 7, 2025
GlobeNewswire
·
April 23, 2025
WEST LAFAYETTE, Ind., April 23, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research …
Zentalis Pharmaceuticals Announces Poster Presentation at 2025 ASCO Annual Meeting
GlobeNewswire
·
April 23, 2025
SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other …
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 23, 2025
BOSTON, April 23, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on January 31, 2025, the company issued inducement awards …
Cardiff Oncology Announces a Second Patent for the Treatment of mCRC for Bev-Naïve Patients
GlobeNewswire
·
April 23, 2025
SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that the United States Patent and …
Sight Sciences Announces the Release of its Sustainability Report
GlobeNewswire
·
April 23, 2025
MENLO PARK, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, announced today …
Dragonfly Energy Announces First Quarter 2025 Preliminary Net Sales and Adjusted EBITDA
GlobeNewswire
·
April 23, 2025
RENO, Nev., April 23, 2025 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. (“Dragonfly Energy” or the “Company”) (Nasdaq: DFLI), an industry leader in energy storage and battery technology, today announced preliminary first quarter 2025 Net Sales and …
Candel Therapeutics Announces Oral Presentation of Positive Phase 3 CAN-2409 Results in Localized Prostate Cancer at ASCO 2025
GlobeNewswire
·
April 23, 2025
NEEDHAM, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today …
EBC Financial Group : iFX EXPO 2025でLATAM市場での存在感や取引環境への貢献を強化
EIN Presswire
·
April 23, 2025
EBC は、金融リテラシーからプラットフォームへのアクセスまで、急速に発展する LATAM の投資家環境に合わせたソリューションに焦点を当てています MEXICO, April 23, 2025 /EINPresswire.com/ -- EBC Financial Group(EBC)は、iFX EXPO LATAM 2025 …
Galapagos Reports First Quarter 2025 Financial Results, Recent Business Highlights and Near-Term Catalysts
GlobeNewswire
·
April 23, 2025
First U.S. patient dosed in ATALANTA-1 study of GLPG5101 Mantle cell lymphoma (MCL), a high-unmet-need hematological malignancy, selected as lead indication for the GLPG5101 program; Pivotal development planned to start in 2026 and aiming for approval in …
Galapagos rapporteert resultaten over het eerste kwartaal van 2025, recente hoogtepunten en verwachtingen op korte termijn
GlobeNewswire
·
April 23, 2025
Eerste Amerikaanse patiënt gedoseerd in ATALANTA-1 studie met GLPG5101 Mantelcellymfoom (MCL), een hematologische maligniteit met een hoge onvervulde behoefte, geselecteerd als hoofdindicatie voor het GLPG5101-programma; pivotale ontwikkeling gepland voor …